XML 74 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Segment information (Tables)
12 Months Ended
Dec. 31, 2025
Notes and other explanatory information [abstract]  
Schedule of present assets and liabilities information for the company operating segments
           

As of December 31, 2025

Undergraduate Continuing education Medical practice solutions Total reportable segments Elimination (inter-segment balances) Total
             
Total assets 8,959,964 245,697 166,238 9,371,899 (13,965) 9,357,934
Current assets 1,765,066 92,221 98,854 1,956,141 (13,965) 1,942,176
Non-current assets 7,194,898 153,476 67,384 7,415,958 - 7,415,758
             
Total liabilities and equity 8,959,964 245,697 166,238 9,371,899 (13,965) 9,357,934
Current liabilities 689,074 113,729 95,203 898,006 (13,965) 884,041
Non-current liabilities 3,474,357 84,581 23,770 3,582,708 - 3,582,708
Equity 4,796,533 47,387 47,265 4,891,185 - 4,891,185
             
Other disclosures            
Investment in associate (i) 46,518 - - 46,518 - 46,518
Capital expenditures (ii) 281,313 79,139 43,559 404,011 - 404,011

 

(i)Investment in UEPC is included in non-current assets in the statement of financial position.
(ii)Capital expenditures consider the acquisitions of property and equipment and intangible assets.

 

As of December 31, 2024 Undergraduate Continuing education Medical practice solutions Total reportable segments Elimination (inter-segment balances) Total
             
Total assets 8,393,185 274,318 170,624 8,838,127 (8,588) 8,829,539
Current assets 1,443,566 71,893 82,913 1,598,372 (8,588) 1,589,784
Non-current assets 6,949,619 202,425 87,711 7,239,755 - 7,239,755
             
Total liabilities and equity 8,393,185 274,318 170,624 8,838,127 (8,588) 8,829,539
Current liabilities 884,705 188,489 75,589 1,148,783 (8,588) 1,140,195
Non-current liabilities 3,279,846 75,619 23,296 3,378,761 - 3,378,761
Equity 4,228,634 10,210 71,739 4,310,583 - 4,310,583
             
Other disclosures            
Investment in associate (i) 54,442 - - 54,442 - 54,442
Capital expenditures (ii) 301,368 53,162 38,085 392,615 - 392,615

 

(i)Investment in UEPC is included in non-current assets in the statement of financial position.
(ii)Capital expenditures consider the acquisitions of property and equipment and intangible assets.
Schedule of statements of income for the company’s operating segments
           

December 31, 2025

Undergraduate Continuing education Medical practice solutions Total reportable segments Elimination (inter-segment transactions) Total
External customer 3,255,426 275,705 166,124 3,697,255 - 3,697,255
Inter-segment - 8,766 5,199 13,965 (13,965) -
Revenue 3,255,426 284,471 171,323 3,711,220 (13,965) 3,697,255
Cost of services (1,176,785) (96,346) (54,729) (1,327,860) 13,965 (1,313,895)
Gross profit 2,078,641 188,125 116,594 2,383,360 - 2,383,360
SG&A expenses           (1,113,065)
Allowance for expected credit losses           (57,090)
Other income           18,762
Other expenses           (18,857)
Operating income           1,213,110
Finance income           194,943
Finance expenses           (561,024)
Share of profit of equity-accounted investee, net of tax           13,916
Income before income taxes           860,945
Income taxes expenses           (92,502)
Net income           768,443

 

December 31, 2024 Undergraduate Continuing education Medical practice solutions Total reportable segments Elimination (inter-segment transactions) Total
External customer 2,895,692 251,636 157,001 3,304,329 - 3,304,329
Inter-segment - 3,802 4,786 8,588 (8,588) -
Revenue 2,895,692 255,438 161,787 3,312,917 (8,588) 3,304,329
Cost of services (1,086,081) (96,180) (41,930) (1,224,191) 8,588 (1,215,603)
Gross profit 1,809,611 159,258 119,857 2,088,726 - 2,088,726
SG&A expenses           (1,008,427)
Allowance for expected credit losses           (60,894)
Other income           13,299
Other expenses           (20,591)
Operating income           1,012,113
Finance income           111,283
Finance expenses           (458,742)
Share of profit of equity-accounted investee, net of tax           11,737
Income before income taxes           676,391
Income taxes expenses           (27,471)
Net income           648,920

 

December 31, 2023 Undergraduate Continuing education Medical practice solutions Total reportable segments Elimination (inter-segment transactions) Total
External customer 2,511,018 227,181 137,714 2,875,913 - 2,875,913
Inter-segment - 8,649 2,568 11,217 (11,217) -
Revenue 2,511,018 235,830 140,282 2,887,130 (11,217) 2,875,913
Cost of services (997,973) (91,915) (31,142) (1,121,030) 11,217 (1,109,813)
Gross profit 1,513,045 143,915 109,140 1,766,100 - 1,766,100
SG&A expenses           (940,132)
Allowance for expected credit losses           (74,552)
Other income           53,206
Other expenses           (37,561)
Operating income           767,061
Finance income           110,642
Finance expenses           (457,616)
Share of profit of equity-accounted investee, net of tax           9,495
Income before income taxes           429,582
Income taxes expenses           (24,166)
Net income           405,416